40 results
PRE 14A
KDNY
Chinook Therapeutics Inc
17 Apr 23
Preliminary proxy
4:51pm
initiatives and adherence to our purpose and company values.
Total Rewards Program
We offer a comprehensive total rewards package that includes … make up a comprehensive package that helps our employees live balanced lives, where they can grow personally and professionally.
Commitment
8-K
EX-1.1
KDNY
Chinook Therapeutics Inc
25 May 22
Chinook Therapeutics Announces Pricing of a $105 Million Public Offering
4:09pm
and the Representatives.
“General Disclosure Package” means any Issuer General Use Free Writing Prospectuses issued at or prior to the Applicable Time, the most recent … not misleading. As of the Applicable Time, none of (A) the General Disclosure Package, (B) any individual Issuer Limited Use Free Writing Prospectus, when
8-K
EX-1.1
wrvgva3kcirps7y5xu
10 Nov 21
Chinook Therapeutics Announces Pricing of an Upsized $160 Million Public Offering
5:24pm
424B3
3wi89w7
26 Aug 20
Prospectus supplement
4:06pm
S-4/A
84m6y mk8
24 Aug 20
Registration of securities issued in business combination transactions (amended)
6:10am
CORRESP
onm3tv6jiwp
24 Aug 20
Correspondence with SEC
12:00am
S-4
rugaf gh69aoe9j
22 Jul 20
Registration of securities issued in business combination transactions
12:00am
425
9krxh2vkn527n
2 Jul 20
Business combination disclosure
4:42pm
8-K
EX-10.1
py31lnmtj5sf47y
2 Jul 20
Departure of Directors or Certain Officers
4:39pm